Australian Public Assessment Report for Cyclizine …

perhaps reflecting the age of these reports (approximately 60 years), the studies were not well designed as part of a human pharmaceutical development regimen, because little information was provided on dose-dependency and specificity of actions; as well, there was a lack of quantifiable measures of the actions of cyclizine (that is, no 50% inhibitory concentration (IC 50) data were provided ... ................
................